These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 29111215)

  • 21. Further experience of using azathioprine in the treatment of severe atopic dermatitis.
    Hughes R; Collins P; Rogers S
    Clin Exp Dermatol; 2008 Nov; 33(6):710-1. PubMed ID: 18681884
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Atopic dermatitis severity and skin barrier impairment.
    Winge MC
    Br J Dermatol; 2014 Mar; 170(3):490-1. PubMed ID: 24617425
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of short-term liver X receptor activation on epidermal barrier features in mild to moderate atopic dermatitis: A randomized controlled trial.
    Czarnowicki T; Dohlman AB; Malik K; Antonini D; Bissonnette R; Chan TC; Zhou L; Wen HC; Estrada Y; Xu H; Bryson C; Shen J; Lala D; Ma'ayan A; McGeehan G; Gregg R; Guttman-Yassky E
    Ann Allergy Asthma Immunol; 2018 Jun; 120(6):631-640.e11. PubMed ID: 29567358
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Skin barrier function and allergic risk.
    Hudson TJ
    Nat Genet; 2006 Apr; 38(4):399-400. PubMed ID: 16570058
    [No Abstract]   [Full Text] [Related]  

  • 25. Contact dermatitis considerations in atopic dermatitis.
    Rundle CW; Bergman D; Goldenberg A; Jacob SE
    Clin Dermatol; 2017; 35(4):367-374. PubMed ID: 28709567
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Filaggrin mutations in early- and late-onset atopic dermatitis.
    Szegedi A
    Br J Dermatol; 2015 Feb; 172(2):320-1. PubMed ID: 25660681
    [No Abstract]   [Full Text] [Related]  

  • 27. Filaggrin mutations and atopy: consequences for future therapeutics.
    Heimall J; Spergel JM
    Expert Rev Clin Immunol; 2012 Feb; 8(2):189-97. PubMed ID: 22288457
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of Raman spectroscopy for the early detection of filaggrin-related atopic dermatitis.
    González FJ; Alda J; Moreno-Cruz B; Martínez-Escanamé M; Ramírez-Elías MG; Torres-Álvarez B; Moncada B
    Skin Res Technol; 2011 Feb; 17(1):45-50. PubMed ID: 20923461
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Profilaggrin, dry skin, and atopic dermatitis risk: size matters.
    McGrath JA
    J Invest Dermatol; 2012 Jan; 132(1):10-1. PubMed ID: 22158606
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Defining intrinsic vs. extrinsic atopic dermatitis.
    Karimkhani C; Silverberg JI; Dellavalle RP
    Dermatol Online J; 2015 Jun; 21(6):. PubMed ID: 26158358
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcome of treatment with azathioprine in severe atopic dermatitis: a 5-year retrospective study of adult outpatients.
    Thomsen SF; Karlsmark T; Clemmensen KK; Graversgaard C; Ibler KS; Jemec GB; Agner T
    Br J Dermatol; 2015 Apr; 172(4):1122-4. PubMed ID: 25350702
    [No Abstract]   [Full Text] [Related]  

  • 32. IL-33 impacts on the skin barrier by downregulating the expression of filaggrin.
    Seltmann J; Roesner LM; von Hesler FW; Wittmann M; Werfel T
    J Allergy Clin Immunol; 2015 Jun; 135(6):1659-61.e4. PubMed ID: 25863977
    [No Abstract]   [Full Text] [Related]  

  • 33. Tolerance of methotrexate in a daily practice cohort of adults with atopic dermatitis.
    Delcasso B; Goujon C; Hacard F; Delcroix F; Grande S; Berard F; Nicolas JF; Nosbaum A
    Eur J Dermatol; 2018 Apr; 28(2):266-267. PubMed ID: 29624179
    [No Abstract]   [Full Text] [Related]  

  • 34. Superficial epidermolytic ichthyosis concomitant with atopic dermatitis.
    Shimada H; Takeo N; Saito-Shono T; Ishikawa K; Sakai T; Goto M; Hatano Y; Fujiwara S; Matsuda M; Hamada T; Nakama T; Hashimoto T; Kono M; Akiyama M; Kitajima Y
    Eur J Dermatol; 2018 Feb; 28(1):94-96. PubMed ID: 29171394
    [No Abstract]   [Full Text] [Related]  

  • 35. Treatment of canine atopic dermatitis with azathioprine: a pilot study.
    Favrot C; Reichmuth P; Olivry T
    Vet Rec; 2007 Apr; 160(15):520-1. PubMed ID: 17435099
    [No Abstract]   [Full Text] [Related]  

  • 36. Building the evidence base for current systemic treatments for severe, chronic atopic dermatitis: methotrexate vs. azathioprine.
    von Kobyletzki LB; Svensson Å
    Br J Dermatol; 2018 Jun; 178(6):1236-1237. PubMed ID: 29897127
    [No Abstract]   [Full Text] [Related]  

  • 37. Information about filaggrin genotype is valuable for adult atopic dermatitis patients.
    Fransen M; Mohammadzadeh P; Bandier J; Overgaard LE; Johansen JD; Thyssen JP
    J Eur Acad Dermatol Venereol; 2017 Mar; 31(3):e156-e158. PubMed ID: 27520506
    [No Abstract]   [Full Text] [Related]  

  • 38. Increased efficacy of omalizumab in atopic dermatitis patients with wild-type filaggrin status and higher serum levels of phosphatidylcholines.
    Hotze M; Baurecht H; Rodríguez E; Chapman-Rothe N; Ollert M; Fölster-Holst R; Adamski J; Illig T; Ring J; Weidinger S
    Allergy; 2014 Jan; 69(1):132-5. PubMed ID: 24111531
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Breaking the (un)sound barrier: filaggrin is a major gene for atopic dermatitis.
    Irvine AD; McLean WH
    J Invest Dermatol; 2006 Jun; 126(6):1200-2. PubMed ID: 16702964
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Filaggrin loss-of-function variant contributes to atopic dermatitis risk in the population of Northern Germany.
    Ruether A; Stoll M; Schwarz T; Schreiber S; Fölster-Holst R
    Br J Dermatol; 2006 Nov; 155(5):1093-4. PubMed ID: 17034559
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.